Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Other Accumulated Expenses: 2014-2024

Historic Other Accumulated Expenses for Surgery Partners (SGRY) over the last 10 years, with FY2024 value amounting to $253.9 million.

  • Surgery Partners' Other Accumulated Expenses fell 152.77% to $238.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.5 million, marking a year-over-year decrease of 152.77%. This contributed to the annual value of $253.9 million for FY2024, which is 2439.98% up from last year.
  • As of FY2024, Surgery Partners' Other Accumulated Expenses stood at $253.9 million, which was up 2439.98% from $204.1 million recorded in FY2023.
  • Surgery Partners' 5-year Other Accumulated Expenses high stood at $253.9 million for FY2024, and its period low was $204.1 million during FY2023.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $210.1 million (2022), whereas its average is $219.0 million.
  • As far as peak fluctuations go, Surgery Partners' Other Accumulated Expenses plummeted by 322.58% in 2021, and later surged by 2439.98% in 2024.
  • Over the past 5 years, Surgery Partners' Other Accumulated Expenses (Annual) stood at $217.0 million in 2020, then decreased by 3.23% to $210.0 million in 2021, then grew by 0.05% to $210.1 million in 2022, then fell by 2.86% to $204.1 million in 2023, then increased by 24.4% to $253.9 million in 2024.
  • Its Other Accumulated Expenses was $253.9 million in FY2024, compared to $204.1 million in FY2023 and $210.1 million in FY2022.